Prevention of chickenpox in reproductive-age women: Cost-effectiveness of routine prenatal screening with postpartum vaccination of susceptibles

Obstetrics and Gynecology

Volumn 92, Issue 4, 1998, Pages 535-545

  Smith, Wendy J ^a,b   Jackson, Lisa A ^a,b   Watts, D Heather ^a,b   Koepsell, Thomas D ^a,b  

^a Seattle Children's Hospital   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHICKENPOX; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; PRENATAL SCREENING; PRIORITY JOURNAL; PUERPERIUM; SERODIAGNOSIS; VACCINATION;

ADULT; CHICKENPOX; CHICKENPOX VACCINE; COST-BENEFIT ANALYSIS; DECISION TREES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; MASS SCREENING; MODELS, ECONOMIC; POSTPARTUM PERIOD; PREGNANCY; PRENATAL CARE; PROGRAM EVALUATION; SENSITIVITY AND SPECIFICITY;

EID: 0031658955     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00221-X     Document Type: Article

References (49)

1. Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications. J Infect Dis 1995;172:706 -12
2. Clements DA, Katz SL. Varicella in a susceptible pregnant woman. Curr Clin Top Infect Dis 1993;13:123-30
3. Preblud SR. Age-specific risks of varicella complications. Pediatrics 1981;68:14 -7
4. Pastuszak AL, Levy M, Schick B, Zuber C, Feldcamp M, Gladstone J, et al. Outcome after varicella infection in the first 20 weeks of pregnancy. N Engl J Med 1994;330:901-5
5. Paryani SG, Arvin AM. Intrauterine infection with varicella-zoster virus after maternal varicella. N Engl J Med 1986;314:1542- 6
6. Zambrano MA, Mart’inez A, M’inguez JA, V’azquez F. Varicella pneumonia complicating pregnancy. Acta Obstet Gynecol Scand 1995;74:318 -20
7. Centers for Disease Control and Prevention. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep 1996;45 (RR-11):1-37
8. American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for the use of live attenuated varicella vaccine. Pediatrics 1995;95:791- 6
9. Varicella related deaths among adults—United States, 1997. MMWR Morb Mortal Wkly Rep 1997;46:409 -12
10. Lieu TA, Cochi SL, Black SB, Halloran ME, Shinefield HR, Holmes SJ, et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA 1994;271:375- 81
11. Lieu TA, Finkler LJ, Sorel ME, Black SB, Shinefield HR. Costeffectiveness of varicella serotesting versus presumptive vaccination of school-age children and adolescents. Pediatrics 1995;95: 632-8
12. Westfall JM, Kallail KJ. Repeat abortion and use of primary care health services. Fam Plann Perspect 1995;27:162-5
13. Conway T, Hu TC, Mason E, Mueller C. Are primary care residents adequately prepared to care for women of reproductive age? Fam Plann Perspect 1995;27:66 -70
14. Struewing JP, Hyams KC, Tueller JE, Gray GC. The risk of measles, mumps, and varicella among young adults: A serosurvey of US Navy and Marine Corps recruits. Am J Public Health 1993;83:1717- 20
15. Kelley PW, Petruccelli BP, Stehr-Green P, Erickson RL, Mason CJ. The susceptibility of young adult Americans to vaccine- 544 Smith et al Cost-Effectiveness of Varicella Serotesting Obstetrics & Gynecology preventable infections. A national serosurvey of US Army recruits. JAMA 1991;266:2724 -9
16. Murray DL, Lynch MA. Determination of immune status to measles, rubella and varicella-zoster viruses among medical students: Assessment of historical information. Am J Public Health 1988;78:836-8
17. Gershon AA, Raker R, Steinberg S, Topf-Olstein B, Drusin LM. Antibody to varicella zoster virus in parturient women and their offspring during the first year of life. Pediatrics 1976;58:692- 6
18. Myers MG, Rasley DA, Hierholzer WJ. Hospital infection control for varicella zoster virus infection. Pediatrics 1982;70:199 -202
19. Final natality statistics, 1992, advance report. Monthly Vital Statistics Report. Washington, DC: National Center for Health Statistics 1994 Oct 25, 43(suppl 4):1- 85
20. Lee SH, Ewert DP, Frederick PD, Mascola L. Resurgence of congenital rubella syndrome in the 1990s: Report on missed opportunities and failed prevention policies among women of childbearing age. JAMA 1992;267:2616 -20
21. Hardy IR, Gershon AA. Prospects for the use of a varicella vaccine in adults. Infect Dis Clin North Am 1990;4:159 -73
22. Demmler GJ, Steinberg SP, Blum G, Gershon AA. Rapid enzymelinked immunosorbent assay for detecting antibody to varicellazoster virus. J Infect Dis 1988;157:211-2
23. Garcia DG, Ewert DP, Mascola L. A survey of hospital postpartum and postabortion rubella vaccination policies in Los Angeles County, 1992. Infect Control Hosp Epidemiol 1993;14:513- 6
24. Huchcroft S, Gunton P, Bowen T. Compliance with postpartum Rh isoimmunization prophylaxis in Alberta. Can Med Assoc J 1985; 133:871-5
25. Londo R, Bjelland T, Girod C, Glasser M. Prenatal and postpartum Pap smears: Do we need both? Fam Pract Res J 1994;14:359-67
26. Stevens-Simon C, O’Connor P, Bassford K. Incentives enhance postpartum compliance among adolescent prenatal patients. J Adolesc Health 1994;15:396 -9
27. Arbeter AM. Clinical trials of varicella vaccine in healthy adolescents and adults. Infect Dis Clin North Am 1996;10:609 -15
28. Arbeter AM, Starr SE, Plotkin SA. Varicella vaccine studies in healthy children and adults. Pediatrics 1986;78:748 -56
29. Gershon AA, LaRussa P, Hardy I, Steinberg S, Silverstein S. Varicella vaccine: The American Experience. J Infect Dis 1992;166 suppl 1:S63- 8
30. Guess HA, Broughton DD, Melton LJ III, Kurland LT. Populationbased studies of varicella complications. Pediatrics 1986;78(suppl): 723-7
31. Gershon AA. Varicella in mother and infant: Problems old and new. In: Krugman S, Gershon AA, eds. Infections of the fetus and the newborn infant. New York: Liss, 1975;79 -95
32. Katz VL, Kuller JA, McMahon MJ, Warren MA, Wells SR. Varicella during pregnancy. Maternal and fetal effects. West J Med 1995;163: 446-50
33. Preblud SR. Varicella: complications and costs. Pediatrics 1986;78: 728-35
34. Rusthoven JJ. The risk of varicella-zoster infections in different patient populations: A critical review. Transfus Med Rev 1994;8: 96-116
35. Lieu TA, Black SB, Rieser N, Ray P., Lewis EM, Shinefield HR. The cost of childhood chickenpox: Parent’s perspective. Pediatr Infect Dis J 1994;13:173-7
36. US Department of Labor. BLS. Employment status of the civilian noninstitutional population by age, sex, and race [table 3]. Employment and Earnings 1993 Jan:174
37. Ghidini A, Lynch L. Management strategies for congenital infections. Mt Sinai J Med 1994;61:376-88
38. Prober CG, Gershon AA, Grose C, McCracken GH Jr, Nelson JD. Consensus: Varicella-zoster infections in pregnancy and the perinatal period. Pediatr Infect Dis J 1990;9:865-9.
39. Hatziandreu E, Palmer CS, Brown RE, Halpern MT. A cost benefit analysis of the diphtheria-tetanus-pertussis (DTP) vaccine. Final report prepared for the National Immunization Program, Centers for Disease Control and Prevention under Contract 200-88-0644 Arlington, Virginia: Batelle Medical Technology Assessment and Policy (MEDTAP) Research Program, Centers for Public Health Research and Evaluation, 1994 Mar 4
40. Table 30, Mean earnings, Year-round full-time workers. Current Population Reports-Consumer Income. 1992;Series P-60(180)
41. Haddix AC, Teutsch SM, Shaffer PA, Dunet DO, eds. Prevention effectiveness: A guide to decision analysis and economic evaluation. New York: Oxford University Press, 1996
42. Weinstein MC, Siegel JE, Gold ME, Kamlet MS, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996;276:1253- 8
43. Margolis HS, Coleman PJ, Brown RE, Mast EE, Sheingold SH, Arevalo JA. Prevention of hepatitis B virus transmission by immunization: A economic analysis of current recommendations. JAMA 1995;274:1201- 8
44. Lindfors KK, Rosenquist CJ. The cost-effectiveness of mammographic screening strategies. JAMA 1995;274:881- 4
45. Longfield JN. Varicella outbreaks in Army recruits from Puerto Rico. Varicella in a population from the tropics. Arch Intern Med 1990;150:970 -3
46. Cassiday WA, Mahoney FJ. A hepatitis B vaccination program targeting adolescents. J Adolesc Health 1995;17:244-7
47. Tsolia M, Gershon AA, Steinberg SP, Gelb L, the National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group. Live attenuated varicella vaccine: Evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. J Pediatr 1990;116:185-9
48. Beazley JM, Hurley R, Middlebrook C, Rumpus MF. Rubella vaccination in the puerperium. Br J Prev Soc Med 1971;25:140 -3
49. Asano Y. Varicella vaccine: The Japanese experience. J Infect Dis 1996;174: suppl 3:S310 -3